Table 4.
Proportion of patients meeting physician-rated CSI-4 screening cut-off scores for ADHD symptoms and psychiatric comorbidities.
| Atomoxetine | Methylphenidate | Nootropic agents | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
||||||||||
| China N=53 | Egypt N=49 | UAE N=23 | Taiwan N=35 | Lebanon N=23 | Russian Fed. N=51 | China N=73 | Egypt N=38 | UAE N=27 | Taiwan N=40 | Lebanon N=36 | Russian Fed. N=91 | |
| ADHD symptoms, n (%) | ||||||||||||
| Combined type | 18 (34.0%) | 21 (46.7%) | 12 (54.5%) | 7 (20.6%) | 8 (34.8%) | 32 (62.7%) | 19 (26.0%) | 8 (21.1%) | 11 (44.0%) | 15 (37.5%) | 13 (36.1%) | 51 (56.0%) |
| Hyperactive-Impulsive type | 23 (43.4%) | 26 (57.8%) | 14 (60.9%) | 11 (32.4%) | 10 (43.5%) | 34 (66.7%) | 28 (38.4%) | 14 (36.8%) | 11 (44.0%) | 18 (45.0%) | 14 (38.9%) | 57 (62.6%) |
| Inattentive type | 30 (56.6%) | 29 (64.4%) | 17 (77.3%) | 13 (37.1%) | 13 (56.5%) | 43 (84.3%) | 39 (53.4%) | 22 (57.9%) | 22 (81.5%) | 23 (57.5%) | 23 (63.9%) | 69 (75.8%) |
| Psychiatric comorbidities, n (%) | ||||||||||||
| ODD | 17 (32.1%) | 19 (42.2%) | 5 (21.7%) | 14 (40.0%) | 11 (47.8%) | 25 (49.0%) | 21 (28.8%) | 16 (42.1%) | 7 (25.9%) | 20 (50.0%) | 11 (30.6%) | 26 (28.6%) |
| Conduct disorder | 7 (13.2%) | 16 (35.6%) | 4 (17.4%) | 5 (14.3%) | 5 (21.7%) | 11 (21.6%) | 10 (13.7%) | 9 (24.3%) | 2 (7.4%) | 8 (20.5%) | 5 (13.9%) | 17 (18.9%) |
| GAD | 3 (5.7%) | 13 (28.9%) | 2 (9.1%) | 6 (18.2%) | 8 (34.8%) | 20 (39.2%) | 6 (8.2%) | 6 (16.2%) | 4 (15.4%) | 6 (15.0%) | 9 (25.0%) | 18 (19.8%) |
| Specific phobia | 28 (52.8%) | 30 (66.7%) | 2 (8.7%) | 23 (65.7%) | 10 (43.5%) | 21 (41.2%) | 36 (49.3%) | 20 (52.6%) | 7 (25.9%) | 22 (55.0%) | 11 (30.6%) | 34 (37.4%) |
| Obsessions | 21 (39.6%) | 14 (31.1%) | 3 (13.0%) | 18 (51.4%) | 7 (30.4%) | 17 (33.3%) | 18 (24.7%) | 10 (26.3%) | 3 (11.1%) | 15 (37.5%) | 6 (16.7%) | 31 (34.1%) |
| Motor tics | 22 (41.5%) | 20 (44.4%) | 3 (13.0%) | 20 (57.1%) | 3 (13.0%) | 12 (23.5%) | 16 (21.9%) | 12 (31.6%) | 4 (14.8%) | 8 (20.0%) | 8 (22.2%) | 27 (29.7%) |
| Vocal tics | 23 (43.4%) | 19 (42.2%) | 3 (13.0%) | 21 (60.0%) | 6 (26.1%) | 13 (25.5%) | 25 (34.2%) | 9 (23.7%) | 2 (7.4%) | 19 (47.5%) | 6 (16.7%) | 31 (34.1%) |
| MDD | 0 (0.0%) | 9 (20.0%) | 1 (4.5%) | 2 (5.7%) | 2 (8.7%) | 4 (7.8%) | 1 (1.4%) | 4 (10.5%) | 0 (0.0%) | 3 (7.5%) | 3 (8.3%) | 4 (4.4%) |
Abbreviations
ADHD, attention deficit hyperactivity disorder; CSI-4, Child Symptom Inventory-4; Fed., Federation; GAD, Generalized anxiety disorder; MDD, Major depressive disorder; n/N, number of patients; ODD, oppositional defiant disorder; UAE, United Arab Emirates.
doi: 10.7573/dic.212260.t004